ReleaseWire Connect

The presence of a large pool of participants, such as Qualcomm Technologies, Texas Instruments, Energized Holdings, Leggett & Platt, Integrated Device Technology, ConvenientPower HK, WiTricity Corp., Powermat Technologies, and PowerbyPoxi, points towards a fragmented and a highly competitive structure of the global market for wireless charging, states a research report by Persistence Market Research (PMR).

Lately, the global pediatric vaccination market has been exhibiting a robust growth. The rise in initiatives by various governments to spread awareness regarding child healthcare, coupled with increasing investments, is propelling the global market to a significant extent. Various upcoming child healthcare programs by UNICEF and the WHO are likely to boost this market in the near future.

Global Pulse Oximeters market is anticipated to grow significantly by year 2015 owing to the increasing penetration in alternate care market, adoption of low perfusion, motion tolerant technology, and increasing use in general care. Pulse Oximeters are used for measuring vital signs of patients as technology provides early warning for hypoxemia – a condition that indicates low arterial blood oxygen saturation level that may prove fatal. However, market is expected to gain momentum in the near future with continuous technological developments and growing implementations in the alternate care market. Introduction of pulse Oximeters with improved features is likely to accelerate the use of these devices in non critical settings, thus opening new opportunities for the market players.

The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of several major drugs.

The global physician dispensed cosmeceuticals market features the presence of prominent names from the skincare and cosmetic industry. The market is currently undergoing a paradigm shift with a large pool of skincare specialists, dermatologists, and trichologists emerging as entrepreneurs, states Transparency Market Research (TMR) in a new study. However, the top three companies, L'Oreal S.A., Valeant Pharmaceuticals Inc., and Allergan plc, held more than 56% of the market in 2015. Of these, L'Oreal S.A. accounted for a larger share of 28% in the same year.

Some of the key players in the global testosterone replacement therapy market include names such as Allergan Plc., AbbVie Inc., Bayer AG., Eli Lilly and Company, Endo Pharmaceuticals, Kyowa Kirin International Plc., Novartis AG., Mylan N.V., and Pfizer Inc. among others. The global market for testosterone replacement therapy is a little bit consolidate with the existence of a few big established companies and the presence of some domestic vendors that are playing their trade in the global market. Companies are now focusing on product development and innovation to enhance their market presence. Recently, Pfizer's new drug, Mylotarg, has been approved by the U.S. Food and Drug Administration, for certain patients who suffer from acute myeloid leukemia (AML). More and more companies are inclining towards getting their products sanctioned and get into the market. This will in turn, help in intensifying the competitive market landscape of the global testosterone replacement therapy market over the course of the given forecast period of 2016 to 2024. The top five companies in the global market held over 80% of the total market share in the 2015 out of which AbbVie Inc. has come up on top as the undisputed leader.

The emergence of sensor technology and continuous advancements in the technology play a pivotal role in the growth of the global market for disposable medical sensors. Disposable medical sensors are available in various types, including implantable sensors, invasive sensors, and ingestible sensors. Implantable sensors are primarily used in medical research for measuring bodily parameters such as temperature, pressure, and force. Invasive sensors are used to detect chemical and physical parameters by inserting a chord or probe inside the human body. Injectable sensors are in form of pills and are swallowed for tracking health and functions inside the human body.

The epidermal growth factor receptor (EGFR) is defined as a transmembrane tyrosine kinase receptor involved in the survival and proliferation of the cancerous cells. Any kind of mutations affecting these EFGR receptors or activity could results in cancer. Mutations lead to over-expresion resulting in large number of cancer, including lung cancer, anal cancer and glioblastoma multiforme. EGFR receptors are the first molecule target against which monoclonal antibodies (mAb) have been designed for cancer treatment. These monoclonal antibodies are sometimes also referred as EGFR antibodies. EGFR antibodies market can be segmented on the basis of the major antibodies which are used against EGFR receptors which include:

Thermo Fisher Scientific, GE Healthcare, DNA Technologies, BioAutomation, Applied Biosystems, GeneDesign, Inc., Eurofins Genomics, Integrated Kaneka Eurogentec S.A., Sigma-Aldrich Corporation, and Agilent Technologies are some of the prominent participants in the global oligonucleotide synthesis market. Among them, Thermo Fisher Scientific is a dominant player that held maximum market share in 2016. Its leading position in the global oligonucleotide synthesis market is a result of its diverse product portfolio and strong outreach. Sigma-Aldrich Corporation comes in the second position in terms of market share.

Umbilical cord blood banking or cord blood banking is the practice of preserving blood from the umbilical cord for future use. Such preserved cord blood is used in medical therapies in the similar approach as that of stem cells derived from bone marrow. Umbilical cord blood banking is practiced for using the cord blood stem cells for the purpose or re-populating blood and treating various medical conditions. Umbilical cord blood is observed to be a potential source of progenitor cells, which can be used for reconstitution of tissue, organs and other functional areas.